/Purdue Pharma Begins Resolution of Opioid Cases With $270 Million Deal

Purdue Pharma Begins Resolution of Opioid Cases With $270 Million Deal

Purdue Pharma LP has forged the first deal to resolve more than 1,600 lawsuits blaming the OxyContin maker for fueling the opioid crisis, a move that could lay the groundwork for the resolution of the rest of the litigation.

The company and its owners, the Sackler family, agreed to pay $270 million to resolve a lawsuit filed by Oklahoma’s attorney general, the majority of which will fund a national opioid addiction center, the two sides said Tuesday.